Clinical Trials Directory

Trials / Completed

CompletedNCT03003897

Meta-analysis of Soluble Fiber Consumption on Body Weight, Glycemia, and Insulinemia in Overweight and Obese Adults.

Effects of Soluble Fiber Consumption on Body Weight, Glycemia, and Insulinemia in Adults With Overweight and Obesity: a Systematic Review and Meta-analysis of Randomized Controlled Trials.

Status
Completed
Phase
Study type
Observational
Enrollment
609 (actual)
Sponsor
University of Illinois at Urbana-Champaign · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Dietary fiber intake is protective against overweight and obesity; however, a significant fiber gap exists between consumption and recommended intake values. Soluble fiber beneficially impacts metabolism, and supplementation may be a feasible approach to improve body composition and glycemia in overweight and obese individuals. The investigators will evaluate results of randomized controlled trials (RCTs) of soluble fiber supplementation among overweight and obese adults for outcomes related to weight management (e.g. body mass index \[BMI\], body weight, body fat percentage, waist circumference) and glucose and insulin homeostasis (e.g. fasting glucose, homeostasis model assessment of insulin resistance \[HOMA-IR\], fasting insulin) through systematic review and meta-analysis.

Conditions

Interventions

TypeNameDescription
OTHERSoluble FiberParticipants receiving soluble fiber.
OTHERPlaceboParticipants receiving placebo.

Timeline

Start date
2016-01-01
Primary completion
2017-08-01
Completion
2017-10-01
First posted
2016-12-28
Last updated
2018-07-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03003897. Inclusion in this directory is not an endorsement.